Stocks
Eli Lilly and Company (LLY) P/FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 48.9 | 75.6 | -166.3 | 1 678 | 107.6 | 67.1 | |||
| Changes by years, y/y, % | +43% | +55% | -320% | -1 109% | -94% | +25.7% | |||
Eli Lilly and Company. P/FCF
Eli Lilly and Company. P/FCF, changes, %
Eli Lilly and Company (LLY) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | -584.1 | -13 943 | 75.9 | 107.6 | 60.6 | 67.1 | ||
| Changes by years, y/y, % | +217% | +5 937% | -121% | -92% | -110% | |||
| Changes by quarters, q/q, % | -143% | +2 287% | -101% | +42% | -44% | |||
